Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass

Anesthesia and Analgesia

Volumn 103, Issue 2, 2006, Pages 289-296

  Cromheecke, Stefanie ^a   Pepermans, Veronik ^a   Hendrickx, Ellen ^a   Lorsomradee, Sur ^a   Ten Broecke, Pieter W ^a   Stockman, Bernard A ^a   Rodrigus, Inez E ^a   De Hert, Stefan G ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; INHALATION ANESTHETIC AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; NADROPARIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; PANCURONIUM BROMIDE; PROPOFOL; REMIFENTANIL; SEVOFLURANE; SULFONYLUREA DERIVATIVE; TROPONIN I;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART PROTECTION; HEART STROKE VOLUME; HUMAN; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; RANDOMIZED CONTROLLED TRIAL;

EID: 33746473049     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000226097.22384.f4     Document Type: Article

References (28)

1. Mangano DT. Biventricular function after myocardial revascularisation in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985;62:571-7.
2. De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
3. De Hert SG, Cromheecke S, ten Broecke PW, et al. Effects of propofol, desflurane and sevoflurane in on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003;99:314-23.
4. De Hert SG, Van der Linden PhD, Cromheecke S, et al. Choice of the anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
5. Conzen PF, Fisher S, Detter C, Peter K. Sevoflurane provides greater protection on the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
6. Bein B, Renner J, Caliebe D, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005;100:610-6.
7. De Hert SG, Rodrigus IE, Haenen LR, et al. Recovery of systolic and diastolic left ventricular function early after cardiopulmonary bypass. Anesthesiology 1996;85:1063-75.
8. Bourdillon PD, Lorell BH, Mirsky I, et al. Increased myocardial stiffness on the left ventricle during pacing-induced ischemia in man. Circulation 1982;67:316-23.
9. Yellin EL, Masatsugu LH, Yoram C, et al. Left ventricular relaxation in the filling and nonfilling canine heart. Am J Physiol 1986;250:H620-9.
10. ATP) channels. Anesthesiology 1996;85:794-807.
11. ATP channels: reduction of myocardial inf arct size with an acute memory phase. Anesthesiology 1997;87:361-70.
12. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997;86:699-709.
13. Toller WG, Kersten JR, Pagel PS, et al. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999;91: 1437-46.
14. ATP channels via multiple signaling pathways. Anesthesiology 2002;97:4-14.
15. Hanouz JL, Yvon A, Massetti M, et al. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vivo. Anesthesiology 2002;97:33-41.
16. Preckel B, Schlack W, Cornière T, et al. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischemia in the rabbit heart in vivo. Br J Anaesth 1998;81:905-12.
17. Schlack W, Preckel B, Srunneck D, Thämer V. Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998;81:913-9.
18. Obal D, Preckel B, Scharbatke H, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001;87:905-11.
19. Belhomme D, Peynet J, Louzy M, et al. Evidence for preconditioning by isoflurane in coronary bypass graft surgery. Circulation 1999;100(suppl II):II340-4.
20. Penta de Peppo A, Polisca P, Tomai F, et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999;68:112-28.
21. Tomai F, De Paulis R, Penta de Peppo A, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999;29:1007-14.
22. Haroun-Bizri S, Khoury SS, Chehab IR, et al. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothor Vasc Anesth 2001;15:418-21.
23. Julier K, de Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27.
24. Nader D, Li CM, Khadra WZ, et al. Anesthetic myocardial protection with sevoflurane. J Cardiothor Vasc Anesth 2004;18:269-74.
25. De Hert SG, Van der Linden PL, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101: 299-310.
26. Van der Linden PJ, Daper A, Trenchant A, De Hert SG. Cardioprotective effects of volatile anesthetics in cardiac surgery. Anesthesiology 2003;99:516-7.
27. Zhang Y, Irwin MG, Wong TM. Remifentanil preconditioning protects against ischemic injury in intact rat heart. Anesthesiology 2004;101:918-23.
28. Zhang Y, Irwin MG, Wong TM, et al. Remifentanil preconditioning confers cardioprotection via cardiac κ- and δ-opioid receptor. Anesthesiology 2005;102:371-8.